Since Boundless Bio was founded in 2018, it has participated in 5 rounds of funding. In total Boundless Bio has raised $374.6M. Boundless Bio's last funding round was on Mar 2024 for a total of $100.0M.
Boundless Bio has 17 investors, including Leaps by Bayer, RA Capital Management and Sectoral Asset Management. The latest investment occurred in Mar 2024.